Kavita Dharmarajan, MD, MSc, assistant professor of radiation oncology and palliative medicine at the Icahn School of Medicine at Mount Sinai Hospital, discusses how patients benefit when healthcare providers look at the “whole picture” in advanced stage cancer treatment.
Kavita Dharmarajan, MD, MSc, assistant professor of radiation oncology and palliative medicine at the Icahn School of Medicine at Mount Sinai Hospital, discusses how patients benefit when healthcare providers look at the “whole picture” in advanced stage cancer treatment.
In a study evaluating 336 patients with stage 4 cancer receiving radiation for symptomatic bone metastases, 161 received a combination of palliative care and radiation therapy and were found to be more likely to finish treatment, have a condensed course of therapy, and be discharged from the hospital an average of six days earlier.
The goal of the study was to establish a basis for palliative care doctors and radiation oncologists to work together to provide better care for patients with advanced stage cancer and take their goals and preferences for treatment into account.
Oncology Nurses Provide Patients an Avenue to Supportive Care
November 12th 2019Palliative care is often associated with a patient entering end of life treatment and giving up on their treatment, but that isn't the reality of what id can do for patients. And oncology nurses can help guide patients to the right supportive care for them.
Hyman B. Muss Discusses the Importance of Nurses in Treating Pregnant Women With Breast Cancer
March 23rd 2016Hyman B. Muss, MD, professor of medicine at the University of North Carolina School of Medicine, discusses the vital roles that nurses play when it comes to treating pregnant women with breast cancer.
Kimberly J. Van Zee on Nomograms Helping in DCIS Treatment Decision-Making
March 18th 2016Kimberly J. Van Zee, MS, MD, FACS, attending surgeon at Memorial Sloan Kettering Cancer Center, discusses the institution's newly-developed nomogram that can help women make treatment decisions about ductal carcinoma in situ (DCIS).